Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 2
2019 4
2020 5
2021 3
2022 8
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients.
Vakrakou AG, Tzanetakos D, Evangelopoulos ME, Fragoulis GE, Kazakou P, Lekka E, Kafasi N, Tzartos JS, Andreadou E, Koutsis G, Gialafos E, Dimitrakopoulos A, Zampeli E, Rontogianni D, Theocharis S, Zapanti E, Stathopoulos PA, Anagnostouli M, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: tzanetakos d. J Neuroimmunol. 2021 Dec 15;361:577759. doi: 10.1016/j.jneuroim.2021.577759. Epub 2021 Oct 29. J Neuroimmunol. 2021. PMID: 34742035
Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.
Vakrakou AG, Evangelopoulos ME, Boutzios G, Tzanetakos D, Tzartos J, Velonakis G, Toulas P, Anagnostouli M, Andreadou E, Koutsis G, Stefanis L, Fragoulis GE, Kilidireas C. Vakrakou AG, et al. Among authors: tzanetakos d. Rheumatol Int. 2020 Feb;40(2):337-343. doi: 10.1007/s00296-019-04502-6. Epub 2020 Jan 2. Rheumatol Int. 2020. PMID: 31898763 Review.
Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Center Experience and a Literature Review.
Theodorou A, Palaiodimou L, Safouris A, Kargiotis O, Psychogios K, Kotsali-Peteinelli V, Foska A, Zouvelou V, Tzavellas E, Tzanetakos D, Zompola C, Tzartos JS, Voumvourakis K, Paraskevas GP, Tsivgoulis G. Theodorou A, et al. Among authors: tzanetakos d. J Clin Med. 2022 Nov 14;11(22):6731. doi: 10.3390/jcm11226731. J Clin Med. 2022. PMID: 36431207 Free PMC article.
Co-occurrence between hereditary angioedema and multiple sclerosis: Therapeutic management of both diseases with fingolimod.
Vakrakou AG, Tzanetakos D, Giagkou E, Evangelopoulos ME, Anagnostouli M, Andreadou E, Koutsis G, Dimitrakopoulos A, Gialafos E, Tzartos JS, Kompoti E, Fragoulis GE, Stefanis L, Kilidireas C. Vakrakou AG, et al. Among authors: tzanetakos d. Clin Neurol Neurosurg. 2022 Mar 28;216:107222. doi: 10.1016/j.clineuro.2022.107222. Online ahead of print. Clin Neurol Neurosurg. 2022. PMID: 35378480
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy.
Karagiorgou K, Dandoulaki M, Mantegazza R, Andreetta F, Furlan R, Lindstrom J, Zisimopoulou P, Chroni E, Kokotis P, Anagnostou E, Tzanetakos D, Breza M, Katsarou Z, Amoiridis G, Mastorodemos V, Bregianni M, Bonakis A, Tsivgoulis G, Voumvourakis K, Tzartos S, Tzartos J. Karagiorgou K, et al. Among authors: tzanetakos d. Neurol Neuroimmunol Neuroinflamm. 2022 Mar 29;9(3):e1162. doi: 10.1212/NXI.0000000000001162. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35351814 Free PMC article.
Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
Tzanetakos D, Tzartos JS, Vakrakou AG, Breza M, Velonakis G, Stathopoulos P, Pantou E, Markakis I, Papadimitriou D, Karavasilis E, Toulas P, Evangelopoulos ΜE, Koutsis G, Anagnostouli M, Stefanis L, Kilidireas C. Tzanetakos D, et al. Mult Scler. 2022 Apr;28(5):718-729. doi: 10.1177/13524585211034362. Epub 2021 Aug 19. Mult Scler. 2022. PMID: 34410179
Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece.
Dardiotis E, Perpati G, Borsos M, Nikolaidis I, Tzanetakos D, Deretzi G, Koutlas E, Kilidireas C, Mitsikostas DD, Hadjigeorgiou G, Grigoriadis N; AURELIO investigators. Dardiotis E, et al. Among authors: tzanetakos d. Neurol Ther. 2022 Sep;11(3):1375-1390. doi: 10.1007/s40120-022-00384-2. Epub 2022 Jul 13. Neurol Ther. 2022. PMID: 35829919 Free PMC article.
Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions-a single-center retrospective observational study.
Gontika M, Skarlis C, Markoglou N, Tzanetakos D, Vakrakou A, Toulas P, Koutsis G, Evangelopoulos ME, Pons R, Dardiotis E, Chrousos G, Dalakas M, Stefanis L, Anagnostouli M. Gontika M, et al. Among authors: tzanetakos d. Naunyn Schmiedebergs Arch Pharmacol. 2022 Aug;395(8):933-943. doi: 10.1007/s00210-022-02238-y. Epub 2022 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35471586
Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS.
Breza M, Koutsis G, Tzartos JS, Velonakis G, Evangelopoulos ME, Tzanetakos D, Karagiorgou K, Angelopoulou G, Kasselimis D, Potagas C, Anagnostouli M, Stefanis L, Kilidireas C. Breza M, et al. Among authors: tzanetakos d. Mult Scler Relat Disord. 2019 Oct;35:156-157. doi: 10.1016/j.msard.2019.07.018. Epub 2019 Jul 24. Mult Scler Relat Disord. 2019. PMID: 31376687 No abstract available.
24 results